Patient-reported outcomes (PROs) are used in clinical trials to provide valuable evidence on
the impact of disease and treatment on patients' symptoms, function and quality of life. High …

Background Rare diseases can lead to a significant reduction in quality of life for patients
and their families. Ensuring the patients voice is central to clinical decision making is key to …

Importance Patient-reported outcome (PRO) data from clinical trials can provide valuable
evidence to inform shared decision making, labeling claims, clinical guidelines, and health …

Background Oral anticoagulation prevents ischemic strokes in patients with atrial fibrillation
(AF). Early detection of AF and subsequent initiation of oral anticoagulation help to prevent …

Patient‐reported outcomes (PRO s) are important in the healthcare system to gain
understanding of patients' views on the effects of a treatment. There is an abundance of …

Objectives Patient-reported outcomes (PROs) provide important information about the
impact of treatment from the patients' perspective. However, missing PRO data may …

Abstract Background Patient-reported outcomes (PROs) are captured within cancer trials to
help future patients and their clinicians make more informed treatment decisions. However …

Purpose To define minimal clinically important difference (MCID) and substantial clinical
benefit (SCB) values for the 12-item International Hip Outcome Tool (iHOT-12) in patients …

Background and objective In comparison to chemotherapy, enfortumab vedotin (EV)
prolonged overall survival in patients with previously treated advanced urothelial carcinoma …

Background Qualitative evidence suggests patient-reported outcome (PRO) information is
frequently absent from clinical trial protocols, potentially leading to inconsistent PRO data …